The healthcare distributor reported adjusted EPS of $2.60, topping estimates, and issued strong fiscal 2027 guidance.
Cardinal Health posted fourth-quarter revenue of $63.67 billion, up nearly 6% year over year but below the $65.03 billion estimate. Adjusted earnings per share reached $2.60, exceeding the $2.42 consensus, excluding a $0.31 tariff refund benefit.
The company’s fiscal 2027 EPS outlook suggests growth above its long-term guidance range, reinforcing confidence in profitability. Shares rose about 1% to $240 after hitting an intraday high of $258.30, nearing record levels.
Earlier intraday and closing highs were $244.01 and $239.71, respectively, set in July and August. The stock’s retreat from peak levels was attributed to profit-taking rather than fundamental concerns.